Kross Ltd has finalized a preferential allotment of 15 lakh equity shares at Rs 212 per share, raising Rs 31.8 crore. Additionally, the company issued 15 lakh convertible warrants to promoters, with 25% of the consideration already received. This dual-action capital infusion expands the company's equity base and signals promoter confidence.
Kross Ltd Executes Rs 31.8 Crore Capital Infusion
Kross Ltd has raised Rs 31.8 crore through a preferential issue of 15,00,000 equity shares at Rs 212 each.
Concurrently, promoters Sumeet Rai and Kunal Rai have been allotted 15,00,000 convertible warrants, with 25% upfront payment received.
Reader Takeaway: Direct cash inflow boosts balance sheet; promoter warrant commitment signals long-term confidence despite equity dilution risks.
What just happened
The Board of Directors at Kross Ltd approved the issuance of 15 lakh equity shares at a price of Rs 212 per share, bringing in Rs 31.8 crore. This move has increased the company's total paid-up equity capital from Rs 32.25 crore to Rs 33.00 crore. Simultaneously, the company issued 15 lakh fully convertible equity warrants to its promoters, Sumeet Rai and Kunal Rai, at the same price of Rs 212 per share. The promoters have already contributed Rs 7.95 crore, representing the mandatory 25% upfront payment for the warrants.
Why this matters
This capital raise provides Kross Ltd with immediate liquidity for its business requirements. By issuing equity to non-promoter entities and warrants to promoters, the company is diversifying its shareholding while ensuring the leadership maintains a significant stake. The conversion period for these warrants is set for 18 months, during which the remaining 75% of the funds will flow into the company if the conversion option is exercised.
Governance and oversight
To ensure transparency and manage the upcoming conversion process, the company has established a 'Capital Management Committee.' This committee, chaired by Independent Director Deepa Verma, will oversee the conversion of warrants into equity shares, providing a layer of corporate governance oversight.
Risks to watch
Investors should be mindful of potential earnings-per-share (EPS) dilution as the equity base has expanded. Furthermore, the warrants carry a forfeiture clause; should the market price or internal conditions change, the non-exercise of these warrants within the 18-month window would result in the forfeiture of the upfront 25% payment, although this serves as an initial buffer for the company.
What to track next
The primary focus for shareholders should be the conversion schedule of the warrants over the next 18 months and the company’s utilization of the newly acquired capital to drive operational growth.
